Overview

Efficacy and Safety Study of Adjunctive Troriluzole in Obsessive Compulsive Disorder

Status:
Recruiting
Trial end date:
2023-03-17
Target enrollment:
Participant gender:
Summary
The study's purpose is to evaluate the efficacy and safety of troriluzole as adjunctive therapy compared to placebo in subjects with Obsessive Compulsive Disorder (OCD)
Phase:
Phase 3
Details
Lead Sponsor:
Biohaven Pharmaceuticals, Inc.